Article
[Low molecular heparin for treatment of venous thrombosis in two very low-birth-weight pre-term infants with genetic risk factors].
Klinische Padiatrie - 1 Jan 2000
Volz S, Schinzel H, Keune N, Neukirch M, Schmidtke S, Stopfkuchen H
Abstract excerpt
We describe the use of low molecular weight heparin to treat venous thrombosis in two very low-birth-weight pre-term infants (GA: 30 and 27 weeks) both with genetic and acquired prothrombotic risk factors. Initially both infants were treated with unfractionated heparin. Since in one infant no effect on the thrombus size was observed and in the other infant there was an increase in size, the anticoagulation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
